Nothing Special   »   [go: up one dir, main page]

EA200870396A1 - Лечение аллергических заболеваний глаз - Google Patents

Лечение аллергических заболеваний глаз

Info

Publication number
EA200870396A1
EA200870396A1 EA200870396A EA200870396A EA200870396A1 EA 200870396 A1 EA200870396 A1 EA 200870396A1 EA 200870396 A EA200870396 A EA 200870396A EA 200870396 A EA200870396 A EA 200870396A EA 200870396 A1 EA200870396 A1 EA 200870396A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
eye diseases
allergy eye
allergy
alkaftadine
Prior art date
Application number
EA200870396A
Other languages
English (en)
Other versions
EA016221B1 (ru
Inventor
Джагдиш Парасрампуриа
Авнер Ингерман
Франс Янссенс
Антон Мегенс
Original Assignee
ВИСТЭКОН ФАРМАСЬЮТИКАЛС, ЭлЭлСи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38468943&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200870396(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ВИСТЭКОН ФАРМАСЬЮТИКАЛС, ЭлЭлСи filed Critical ВИСТЭКОН ФАРМАСЬЮТИКАЛС, ЭлЭлСи
Publication of EA200870396A1 publication Critical patent/EA200870396A1/ru
Publication of EA016221B1 publication Critical patent/EA016221B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Композиции, наборы и способы для лечения или предупреждения аллергических заболеваний и воспаления глаз и их симптомов, содержащие алкафтадин или его фармацевтически приемлемую соль.
EA200870396A 2006-03-31 2007-03-26 Офтальмические композиции и способ лечения аллергических заболеваний глаз EA016221B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78818506P 2006-03-31 2006-03-31
US68801607A 2007-03-19 2007-03-19
PCT/US2007/064911 WO2007117971A2 (en) 2006-03-31 2007-03-26 Ocular allergy treatments

Publications (2)

Publication Number Publication Date
EA200870396A1 true EA200870396A1 (ru) 2009-04-28
EA016221B1 EA016221B1 (ru) 2012-03-30

Family

ID=38468943

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200870396A EA016221B1 (ru) 2006-03-31 2007-03-26 Офтальмические композиции и способ лечения аллергических заболеваний глаз

Country Status (30)

Country Link
US (7) US8664215B2 (ru)
EP (2) EP2004196B1 (ru)
JP (3) JP5292277B2 (ru)
KR (1) KR101321731B1 (ru)
CN (1) CN102895234A (ru)
AR (1) AR060278A1 (ru)
AU (1) AU2007234957B2 (ru)
BR (1) BRPI0710085B8 (ru)
CA (1) CA2648115C (ru)
CL (1) CL2007000916A1 (ru)
CR (1) CR10414A (ru)
DK (2) DK3150209T3 (ru)
EA (1) EA016221B1 (ru)
EC (1) ECSP088786A (ru)
ES (2) ES2594655T3 (ru)
HK (1) HK1131331A1 (ru)
IL (1) IL194473A (ru)
JO (1) JO3358B1 (ru)
MX (1) MX2008012657A (ru)
MY (1) MY153669A (ru)
NI (1) NI200800261A (ru)
NO (1) NO341147B1 (ru)
NZ (1) NZ571690A (ru)
PE (1) PE20080053A1 (ru)
PL (2) PL2004196T3 (ru)
SG (1) SG170044A1 (ru)
TW (2) TWI578990B (ru)
UY (1) UY30254A1 (ru)
WO (1) WO2007117971A2 (ru)
ZA (1) ZA200809327B (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102895234A (zh) 2006-03-31 2013-01-30 维斯塔肯药品有限责任公司 眼变态反应治疗
EP2015733A2 (en) 2006-04-26 2009-01-21 Aciex, Inc. Compositions for the treatment and prevention of eyelid swelling
MX2010005012A (es) * 2007-11-08 2010-06-23 Aciex Therapeutics Inc Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
JP6033677B2 (ja) 2009-03-17 2016-11-30 ナイコックス オフサルミクス， インコーポレイテッド セチリジンの眼科用製剤および使用方法
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
US9409913B2 (en) * 2012-11-21 2016-08-09 Enaltec Labs Private Limited Polymorphic forms of alcaftadine
WO2014087208A2 (en) * 2012-12-06 2014-06-12 Enaltec Labs Pvt. Ltd. A process of preparing alcaftadine
KR102275012B1 (ko) 2016-08-12 2021-07-07 실크 테크놀로지스 리미티드 염증 치료용 실크 유래 단백질
JP7191022B2 (ja) * 2017-07-28 2022-12-16 参天製薬株式会社 アルカフタジン又はその塩を含有する水性医薬組成物
JPWO2019026992A1 (ja) * 2017-08-03 2020-06-18 参天製薬株式会社 クロルヘキシジンを含有する医薬組成物
DK3740191T3 (da) 2018-01-18 2021-06-07 Faes Farma Sa Oftalmiske sammensætninger omfattende bilastin, et beta-cyclodextrin og mindst et geleringsmiddel
US20230218630A1 (en) 2020-06-15 2023-07-13 Alkem Laboratories Limited Combination of alcaftadine and a corticosteroid
US12023276B2 (en) 2021-02-24 2024-07-02 Ocular Therapeutix, Inc. Intracanalicular depot inserter device
CN117120029A (zh) 2021-04-01 2023-11-24 阿尔克姆实验室有限公司 包含阿卡他定的鼻用组合物
TW202408468A (zh) * 2022-07-06 2024-03-01 日商樂敦製藥股份有限公司 眼科組成物
WO2024010039A1 (ja) * 2022-07-06 2024-01-11 ロート製薬株式会社 眼科組成物
WO2024204749A1 (ja) * 2023-03-31 2024-10-03 ロート製薬株式会社 眼科組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148903A (en) 1977-07-28 1979-04-10 Merck & Co., Inc. Antipsychotic, antiserotonin and antihistaminic pyrrolo[2,1-b][3]benzazepines
DE3134672A1 (de) * 1981-09-02 1983-03-17 Boehringer Ingelheim KG, 6507 Ingelheim Heterocyclische verbindungen, ihre herstellung und verwendung
GB8900380D0 (en) 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
EP0552292B1 (en) * 1990-10-10 1995-06-21 Schering Corporation Substituted imidazobenzazepines and imidazopyridoazepines
IT1248014B (it) * 1991-06-07 1995-01-05 Inverni Della Beffa Spa Preparazioni oftalmiche a rilascio protratto
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
US20060100408A1 (en) * 2002-03-11 2006-05-11 Powell P M Method for forming contact lenses comprising therapeutic agents
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
US20070077303A1 (en) 2005-09-30 2007-04-05 Azaam Alli Methods for providing oxidatively stable ophthalmic compositions
KR20140083056A (ko) 2006-03-17 2014-07-03 존슨 앤드 존슨 비젼 케어, 인코포레이티드 산화에 불안정한 성분을 포함하는 안정화된 안과용 조성물
CN102895234A (zh) 2006-03-31 2013-01-30 维斯塔肯药品有限责任公司 眼变态反应治疗

Also Published As

Publication number Publication date
EP2004196A2 (en) 2008-12-24
US10617695B2 (en) 2020-04-14
TW200815016A (en) 2008-04-01
DK2004196T3 (en) 2016-09-05
CA2648115C (en) 2015-03-24
CL2007000916A1 (es) 2008-01-25
IL194473A (en) 2016-04-21
US8664215B2 (en) 2014-03-04
JP2009533333A (ja) 2009-09-17
CR10414A (es) 2009-02-23
JP6039716B2 (ja) 2016-12-07
US20230181594A1 (en) 2023-06-15
SG170044A1 (en) 2011-04-29
HK1131331A1 (en) 2010-01-22
KR20080110881A (ko) 2008-12-19
AU2007234957B2 (en) 2012-12-13
TWI578990B (zh) 2017-04-21
EP3150209A1 (en) 2017-04-05
WO2007117971A2 (en) 2007-10-18
EA016221B1 (ru) 2012-03-30
CN102895234A (zh) 2013-01-30
ECSP088786A (es) 2009-01-30
IL194473A0 (en) 2009-08-03
NO341147B1 (no) 2017-09-04
ES2752823T3 (es) 2020-04-06
US20140107102A1 (en) 2014-04-17
EP3150209B1 (en) 2019-07-24
TW201446249A (zh) 2014-12-16
UY30254A1 (es) 2007-08-31
MY153669A (en) 2015-03-13
KR101321731B1 (ko) 2013-10-30
DK3150209T3 (da) 2019-10-28
JP2013144703A (ja) 2013-07-25
TWI450721B (zh) 2014-09-01
EP2004196B1 (en) 2016-06-29
ZA200809327B (en) 2009-12-30
ES2594655T3 (es) 2016-12-21
US20210030762A1 (en) 2021-02-04
BRPI0710085A2 (pt) 2011-08-23
AU2007234957A1 (en) 2007-10-18
NZ571690A (en) 2011-09-30
CA2648115A1 (en) 2007-10-18
BRPI0710085B1 (pt) 2019-12-17
US20170065605A1 (en) 2017-03-09
US20080051385A1 (en) 2008-02-28
WO2007117971A3 (en) 2007-12-27
JO3358B1 (ar) 2019-03-13
US20120094978A1 (en) 2012-04-19
PL3150209T3 (pl) 2020-03-31
MX2008012657A (es) 2009-02-19
JP5292277B2 (ja) 2013-09-18
NO20084593L (no) 2008-10-29
NI200800261A (es) 2012-10-30
PE20080053A1 (es) 2008-03-10
JP2015131820A (ja) 2015-07-23
PL2004196T3 (pl) 2017-01-31
BRPI0710085B8 (pt) 2021-05-25
AR060278A1 (es) 2008-06-04
US20240058355A1 (en) 2024-02-22

Similar Documents

Publication Publication Date Title
EA200870396A1 (ru) Лечение аллергических заболеваний глаз
EA200901211A1 (ru) Антигены белка с5 и их применение
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
WO2008029276A3 (en) Compositions and methods for the treatment of ophthalmic disease
EA201370208A1 (ru) Формы рифаксимина и их применение
CO6300826A2 (es) Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf
ATE502633T1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
EA200901486A1 (ru) СОЕДИНЕНИЯ И КОМПОЗИЦИИ, КАК ИНГИБИТОРЫ КИНАЗЫ c-KIT И PDGFR
EA201170349A1 (ru) Модуляторы mif
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
CR10347A (es) Anticuerpos contra el peptidob-amiloide
EA201071243A1 (ru) Комбинированные композиции для лечения болезни альцгеймера и родственных заболеваний зонизамидом и акампросатом
EA201290209A1 (ru) Новые модуляторы бензопиран киназы
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA200870185A1 (ru) Комбинации ингибиторов ang2 и vegf
EA200700333A1 (ru) Терапевтические применения ингибиторов rtp801
EA200800763A1 (ru) Терапевтические композиции, содержащие гиалуроновую кислоту и терапевтические антитела, а также способы лечения
EA201001865A1 (ru) Противовоспалительные агенты
EA200970946A1 (ru) Комбинированная терапия антикоагулирующего средства с соединением, которое действует как ингибитор фактора ха
EA200801997A1 (ru) Новые соединения
EA201300471A1 (ru) Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3
AR059928A1 (es) Metodos y dispositivos oftalmicos usados en el tratamiento de alergias oculares
EA200901484A1 (ru) СОЕДИНЕНИЯ И КОМПОЗИЦИИ КАК ИНГИБИТОРЫ КИНАЗЫ c-KIT И PDGFR
NO20083751L (no) Metoder for behandling av kognitive og andre sykdommer
CO6592047A2 (es) Formulación tópica oftálmica de péptidos

Legal Events

Date Code Title Description
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title